## **Core Concept**
The question revolves around the management of urinary tract infections (UTIs) in pregnancy. UTIs are common during pregnancy due to physiological changes that predispose women to infections. The presence of bacteriuria, along with symptoms like urinary frequency, urgency, and dysuria, indicates a UTI that requires prompt treatment to prevent complications such as pyelonephritis, preterm labor, and low birth weight.
## **Why the Correct Answer is Right**
The correct answer, **C. Nitrofurantoin**, is appropriate for treating UTIs in pregnancy, particularly in the first and second trimesters. Nitrofurantoin is effective against the most common urinary pathogens and has a long history of safe use in pregnancy. It is often recommended for asymptomatic bacteriuria and symptomatic UTIs in pregnant women, especially when the infection is confined to the lower urinary tract.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, one might consider other antibiotics. However, without the specific option, we focus on why common alternatives might be incorrect.
- **Option B:** This option is also not provided, but generally, certain antibiotics like tetracyclines and fluoroquinolones are avoided in pregnancy due to potential risks to the fetus.
- **Option D:** Similarly, without specifics, one might think of other antibiotics that are not first-line or are contraindicated in pregnancy.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **asymptomatic bacteriuria in pregnancy** should be treated to prevent progression to pyelonephritis. Nitrofurantoin is a commonly recommended agent, but resistance patterns should be considered. In the third trimester, the risk of pyelonephritis increases, and **cefexime** or **ampicillin** with **gentamicin** might be considered based on culture and sensitivity.
## **Correct Answer: C. Nitrofurantoin**
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.